tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mersana Therapeutics Reports Positive Phase 1 Trial Results
PremiumCompany AnnouncementsMersana Therapeutics Reports Positive Phase 1 Trial Results
2M ago
Mersana Therapeutics reports additional interim Phase 1 data for Emi-Le
Premium
The Fly
Mersana Therapeutics reports additional interim Phase 1 data for Emi-Le
2M ago
Promising Clinical Trial Data and Upcoming Presentations Bolster Buy Rating for Mersana Therapeutics
Premium
Ratings
Promising Clinical Trial Data and Upcoming Presentations Bolster Buy Rating for Mersana Therapeutics
2M ago
Positive Developments in Mersana Therapeutics’ TNBC Trials and Stable Financial Position Support Buy Rating
PremiumRatingsPositive Developments in Mersana Therapeutics’ TNBC Trials and Stable Financial Position Support Buy Rating
2M ago
Promising Clinical Trial Results and Strategic Development Drive Buy Rating for Mersana Therapeutics
Premium
Ratings
Promising Clinical Trial Results and Strategic Development Drive Buy Rating for Mersana Therapeutics
2M ago
Mersana Therapeutics reports Q1 EPS (19c), consensus (19c)
Premium
The Fly
Mersana Therapeutics reports Q1 EPS (19c), consensus (19c)
2M ago
Positive Outlook for Mersana Therapeutics Amid Strategic Developments and Financial Stability
PremiumRatingsPositive Outlook for Mersana Therapeutics Amid Strategic Developments and Financial Stability
5M ago
Positive Outlook for Mersana Therapeutics: Buy Rating Backed by Promising Pipeline and Strong Financial Position
Premium
Ratings
Positive Outlook for Mersana Therapeutics: Buy Rating Backed by Promising Pipeline and Strong Financial Position
5M ago
Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges
Premium
Company Announcements
Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100